Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have been assigned an average recommendation of “Buy” from the ten brokerages that are covering the company, MarketBeat reports. Five equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $606.67.

MTD has been the topic of a number of research reports. Zacks Investment Research cut Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Tuesday, November 7th. Morgan Stanley boosted their price objective on Mettler-Toledo International from $535.00 to $545.00 and gave the company an “equal weight” rating in a research report on Friday, November 3rd. Robert W. Baird boosted their price objective on Mettler-Toledo International from $605.00 to $675.00 and gave the company a “neutral” rating in a research report on Friday, November 3rd. Jefferies Group LLC restated a “hold” rating and set a $600.00 price objective on shares of Mettler-Toledo International in a research report on Friday, October 20th. Finally, Bank of America Corporation boosted their price objective on Mettler-Toledo International from $640.00 to $710.00 and gave the company a “buy” rating in a research report on Monday, October 9th.

In related news, insider Christian Magloth sold 750 shares of the business’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $590.00, for a total value of $442,500.00. Following the sale, the insider now owns 750 shares of the company’s stock, valued at approximately $442,500. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Waldemar Rauch sold 2,203 shares of the business’s stock in a transaction on Monday, August 28th. The shares were sold at an average price of $594.27, for a total value of $1,309,176.81. Following the completion of the sale, the insider now directly owns 7,771 shares in the company, valued at approximately $4,618,072.17. The disclosure for this sale can be found here. In the last ninety days, insiders sold 43,591 shares of company stock worth $27,262,591. 5.20% of the stock is owned by insiders.

A number of hedge funds have recently made changes to their positions in MTD. NN Investment Partners Holdings N.V. boosted its stake in Mettler-Toledo International by 643.9% in the second quarter. NN Investment Partners Holdings N.V. now owns 1,458 shares of the medical instruments supplier’s stock worth $858,000 after purchasing an additional 1,262 shares in the last quarter. Creative Planning boosted its stake in Mettler-Toledo International by 14.0% in the second quarter. Creative Planning now owns 1,312 shares of the medical instruments supplier’s stock worth $772,000 after purchasing an additional 161 shares in the last quarter. Aperio Group LLC boosted its stake in Mettler-Toledo International by 20.7% in the second quarter. Aperio Group LLC now owns 17,643 shares of the medical instruments supplier’s stock worth $10,384,000 after purchasing an additional 3,028 shares in the last quarter. Murphy Capital Management Inc. acquired a new position in Mettler-Toledo International in the second quarter worth $235,000. Finally, Meag Munich Ergo Kapitalanlagegesellschaft MBH acquired a new position in Mettler-Toledo International in the second quarter worth $2,536,000. 93.38% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/11/22/mettler-toledo-international-inc-mtd-receives-606-67-consensus-pt-from-brokerages.html.

Shares of Mettler-Toledo International (NYSE MTD) traded down $4.30 during midday trading on Friday, reaching $627.62. The company’s stock had a trading volume of 94,800 shares, compared to its average volume of 157,917. The company has a current ratio of 1.51, a quick ratio of 1.11 and a debt-to-equity ratio of 2.05. The company has a market cap of $16,163.96, a P/E ratio of 37.39, a P/E/G ratio of 2.89 and a beta of 1.13. Mettler-Toledo International has a 52 week low of $407.87 and a 52 week high of $694.48.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $4.36 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $4.32 by $0.04. The company had revenue of $698.80 million for the quarter, compared to the consensus estimate of $685.56 million. Mettler-Toledo International had a return on equity of 96.81% and a net margin of 16.44%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the business posted $3.89 EPS. sell-side analysts expect that Mettler-Toledo International will post 17.52 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.